Page last updated: 2024-12-04

beta-phosphonopropionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-phosphonopropionic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1682
CHEMBL ID1088324
SCHEMBL ID23648
MeSH IDM0044098

Synonyms (41)

Synonym
3-phosphonopropionic acid ,
beta-phosphonopropionic acid
einecs 227-738-8
propanoic acid, 3-phosphono-
3-phosphopropionic acid
3-phosphonopropanoic acid
5962-42-5
1IIG ,
DB03379
2-carboxyethylphosphonic acid
3-phosphonopropionic acid, technical grade, 94%
bdbm50311531
(2-carboxyethyl)-phosphonic acid
CHEMBL1088324 ,
AKOS003600208
STK041913
unii-8dm1r7808m
carboxyethylphosphonic acid
cepa cpd
3-phosphopropionate
8dm1r7808m ,
FT-0616356
SCHEMBL23648
NLBSQHGCGGFVJW-UHFFFAOYSA-N
3-phosphonoproprionic acid
DTXSID3064069
3-phosphonopropionicacid
(2-carboxyethyl)phosphonic acid
P2348
Q27094318
AS-10393
C93494
A927956
.beta.-phosphonopropionic acid
1-carboxyethane-2-phosphonic acid
mfcd00002770
3-phosphonopropionic acid, tech.
PD007039
CS-W018060
3-phosphonopropanoicacid
2-carboxyethanephosphonic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain B, TRIOSEPHOSPHATE ISOMERASETrypanosoma brucei bruceiKi27,000.000027,000.000027,000.000027,000.0000AID977610
Chain B, TRIOSEPHOSPHATE ISOMERASETrypanosoma brucei bruceiKi27,000.000027,000.000027,000.000027,000.0000AID977610
Chain B, Triosephosphate IsomeraseTrypanosoma brucei bruceiKi27,000.000027,000.000027,000.000027,000.0000AID977610
Succinyl-diaminopimelate desuccinylaseHaemophilus influenzae Rd KW20IC50 (µMol)1,620.00003.30003.30003.3000AID467024
Succinyl-diaminopimelate desuccinylaseHaemophilus influenzae Rd KW20Ki800.00001.82001.82001.8200AID467024
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID467024Inhibition of Haemophilus influenzae recombinant DapE2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity.
AID1565284Inhibition of red kidney bean PAP using pNPP as substrate2019European journal of medicinal chemistry, Nov-15, Volume: 182Synthesis, evaluation and structural investigations of potent purple acid phosphatase inhibitors as drug leads for osteoporosis.
AID1128904Inhibition of red kidney beans purple acid phosphatase2014European journal of medicinal chemistry, Apr-09, Volume: 76The applications of binuclear metallohydrolases in medicine: recent advances in the design and development of novel drug leads for purple acid phosphatases, metallo-β-lactamases and arginases.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1991Proteins, , Volume: 10, Issue:1
The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes.
AID1811Experimentally measured binding affinity data derived from PDB1991Proteins, , Volume: 10, Issue:1
The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's1 (7.14)18.2507
2000's3 (21.43)29.6817
2010's9 (64.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]